Anesthesia for Patients with Chronic Drug Use or Addiction

Managing anesthesia for patients with chronic drug use or addiction presents unique challenges that require careful assessment, planning, and a tailored approach to mitigate potential risks. These patients often have complex medical histories, altered physiological responses, and a higher likelihood of complications during and after surgery. Therefore, a comprehensive preoperative evaluation is essential to ensure their safety and optimize outcomes.

Managing Opioid-Dependent Patients

Patients on chronic opioid therapy or those enrolled in methadone or buprenorphine maintenance programs require special consideration. These patients often develop significant tolerance to opioids, meaning they may need higher doses of pain medications to achieve adequate analgesia. However, increasing opioid doses can heighten the risk of respiratory depression, sedation, and other complications, making it a delicate balance for anesthesia providers.

A multimodal approach to pain management is typically the most effective strategy for these patients. This approach combines non-opioid analgesics, such as acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs), with regional anesthesia techniques, like nerve blocks or epidurals, which can provide effective pain relief while minimizing opioid use. Additionally, adjuvant therapies such as gabapentinoids (gabapentin or pregabalin) and low-dose ketamine may be utilized to enhance analgesia and reduce opioid requirements.

For patients on methadone or buprenorphine maintenance therapy, it is crucial to continue their regular doses throughout the perioperative period. Abrupt discontinuation can precipitate withdrawal symptoms, which can be severe and difficult to manage. Coordination with the patient's addiction specialist or prescribing physician is essential to ensure that maintenance therapy is appropriately managed. In some cases, a temporary adjustment of the methadone or buprenorphine dose may be necessary to balance pain control with the risk of withdrawal.

Addressing Alcohol Dependence

Patients with a history of alcohol dependence also require careful management, particularly to prevent alcohol withdrawal syndrome (AWS), which can range from mild symptoms like tremors and anxiety to severe manifestations such as seizures and delirium tremens (DTs). DTs are especially dangerous, with a high risk of mortality if not promptly recognized and treated. Withdrawal follows a predictable course after the last drink: tremor, anxiety, and autonomic signs begin within about 6 to 12 hours, hallucinations at 12 to 24 hours, seizures most often at 12 to 48 hours, and delirium tremens at 48 to 72 hours (occasionally later), which is why a patient fasted and admitted the night before surgery can first show withdrawal in the operating room or recovery area. Thiamine should be given before any glucose-containing fluid to avoid precipitating Wernicke encephalopathy.

Preoperative planning should include strategies to prevent or manage AWS. This may involve the use of benzodiazepines, which are the mainstay of treatment for alcohol withdrawal. Medications such as lorazepam or diazepam can be administered on a symptom-triggered basis or at scheduled intervals, depending on the patient’s risk factors and clinical status. For patients with severe withdrawal symptoms or those at high risk for DTs, additional monitoring in a critical care setting may be warranted. Other agents, such as clonidine or dexmedetomidine, can be used as adjuncts to manage autonomic hyperactivity and provide additional sedation.